TY  - GEN
AU  - Lim,Soon-Thye
AU  - Fayad,L
AU  - Tulpule,A
AU  - Modiano,M
AU  - Cabanillas,F
AU  - Laffranchi,B
AU  - Allievi,C
AU  - Bernareggi,A
AU  - Levine,Alexandra M
TI  - A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma
SN  - 1042-8194
PY  - 2007///0503
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacokinetics
KW  - Cisplatin
KW  - administration & dosage
KW  - Cytarabine
KW  - Female
KW  - Humans
KW  - Isoquinolines
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Lymphoma, Follicular
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Methylprednisolone
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Prospective Studies
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1080/10428190601060496
ER  -